
Rescheduled Midcycle Meeting Email, April 15, 2009, Anascorp

 
 
From:                     Brony, Michael
Sent:                      Wednesday, April 15, 2009 3:54 PM
To:                         Cordaro, Debbie
Subject:                 RE: Rescheduled Midcycle Meeting;STN 125335/0;Bioclon;Scorpion Antivenin;

Hi Debbie,

 

This is e-mail is to let you know that the proprietary name review for Anascorp BLA 125335/0 is ongoing and will be completed by the May 22nd PDUFA date.

 

Thanks

 

Michael

 

_____________________________________________

From:                     Cordaro, Debbie 

Sent:                      Wednesday, April 15, 2009 3:46 PM

To:                          Fisher, Robert; Brony, Michael; Frazier, Douglas; Kennedy, Michael; Ko, Hon Sum; Mahmood, Iftekhar; Ou, Alan C.; Wesley, Robert; Zhang, Pei; Zinderman, Craig E; Beren, Joel; Lin, Xue; Ward- Peralta, Cherie

Cc:                          Jain, Nisha; Gupta, Ghanshyam; Scott, Dorothy

Subject:                Rescheduled Midcycle Meeting;STN 125335/0;Bioclon;Scorpion Antivenin;

 

Just a reminder that tomorrow is our midcycle meeting. As of a few minutes ago, there have been very few memos uploaded to the EDR. After tomorrow's meeting I will need to provide the OBRR management the status of this committee, i.e., who has submitted their memos. Please make every effort to complete your memo before we meet.


See you tomorrow,

Debbie

 

 

Debbie Cordaro

 

Debbie Cordaro

Regulatory Project Manager

OBRR

Voice: 301-827-6157 Fax 301-827-2857

debbie.cordaro@fda.hhs.gov

 